Enzyme Therapeutic for Ischemia and Reperfusion Injury in Organ Transplantation

Ischemia-reperfusion injury (IRI) remains as a critical challenge for organ transplantation. Herein, an enzyme therapeutic based on superoxide dismutase and catalase for effective mitigation of IRI and pathogen-induced liver injury is reported, providing a therapeutic for organ transplantation and other diseases.

Automated summary

This study presents an enzyme therapeutic approach based on superoxide dismutase and catalase for alleviating ischemia-reperfusion injury and pathogen-induced liver injury, offering a potential treatment for organ transplantation and other diseases.